{
    "N/R/U": null,
    "Applicant": "Neurotech Pharmaceuticals Inc.",
    "BLA Number": "125798",
    "Proprietary Name": "encelto",
    "Proper Name": "revakinagene taroretcel-lwey",
    "BLA Type": "351(a)",
    "Strength": "200,000-440,000CELLS/IMPLANT",
    "Dosage Form": "Implant",
    "Route of Administration": "Implantation",
    "Product Presentation": "Capsule",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "March 05, 2025",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2321",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}